Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Trends Cardiovasc Med. 2021 Oct 5;32(8):487–498. doi: 10.1016/j.tcm.2021.09.010

Table 2. Studies investigating the effects of PM2.5 in cardiovascular homeostasis and function.

This table summarizes in vitro and in vivo studies published to date investigating the physiological effects of PM2.5 in cardiovascular system, which show association between PM2.5 intoxication and CVDs. PM; particulate matter. NIST; National Institutes of Standards and Technology. eNOS; endothelial nitric oxide synthase.

Disease type Phenotype Species Species or cell lines used for investigation Exp. Type Treatment method Treatment dosage & duration Source of PM2.5 Ref.
Cardiac dysfunction Cardiac ATP synthesis abnormality Rat H9c2 (rat cardiomyocyte cell line) In vitro Submerged cell culture 1–10 μg/cm2 PM2.5 for 24 h Taiyuan, China [29]
Cardiac dysfunction Functional cardiotoxicities, mitochondrial dysfunction, DNA damage Rat Neonatal rat cardiomyocyte (NRCM) In vitro Submerged cell culture 25, 50, 75, 100, 200 and 400 μg/ml for 48 h Taiyuan, China [55]
Cardiac dysfunction Contractile dysfunction, reduced calcium handling ability Rat Sprague Dawley (SD) rat cardiomyocytes In vitro Submerged cell culture 0.25, 0.50, 1.0, and 25 μg/ml for 1h Diesel exhaust particle (DEP), NIST Standard Reference Matter (SRM) 1650b [64]
Cardiac dysfunction Exacerbates High Glucose-Induced Cardiomyocyte Dysfunction through ROS Generation Rat Sprague Dawley (SD) rat cardiomyocytes In vitro Submerged cell culture 0.1 μg/ml for 24h Diesel exhaust particle (DEP), NIST Standard Reference Matter (SRM) 1650b [54]
Cardiac dysfunction Mitochondria-mediated apoptosis Human AC16 In vitro Submerged cell culture 25, 50, and 100 μg/ml for 24h Beijing, China [58]
Cardiac dysfunction Cardiac ATP synthesis abnormality; functional decrement of myocardium Rat Sprague Dawley (SD) rats In vivo Intratracheal instillation summer PM2.5 groups (0.2, 0.6, 1.5 mg/kg, and winter PM2.5 group (0.3, 1.5, 2.7 mg/kg), once every 3 days for 2 months Taiyuan, China [29]
Cardiac dysfunction Cardiac fibrosis Mouse C57BL/6 mice In vivo Oropharyngeal aspiration 3 mg/kg every other day for 4 weeks Taiyuan, China [36]
Cardiac dysfunction Myocardial Ischemia/Reperfusion Injury Through Farnesoid-X-Receptor-Induced Autophagy Rat Sprague Dawley (SD) rats In vivo Intratracheal instillation 6.67 mg/ml for 24 h Lanzhou, China [60]
Cardiac dysfunction Autophagy; decreased myocardial layers in the heart Zebrafis h Zebrafish embryos; wildtype zebrafish (AB strain) and transgenic zebrafish (Tg:zlyz-enhanced green fluorescent protein (EGFP)) In vivo Submerged cell culture 200, 300, 400, 500, 600, and 800 μg/ml for 120 h Jinan, China [56]
Cardiac dysfunction Fibrosis, myocardial remodeling, inflammatory response, oxidative stress Rat Wistar rats In vivo Exposure chamber daily average of between 600–800 μg/m3, 5 days a week, for 4 weeks, or 7 weeks São Paulo, Brazil [52]
Cardiac dysfunction Fibrosis, myocardial remodeling, inflammatory response, oxidative stress Mouse BALB/c mice In vivo Intratracheal instillation 4.0 mg/kg, once per day for 5 consecutive days China [49]
Cardiac dysfunction Cardiomyopathy confers susceptibility to particulate matter-induced oxidative stress, vagal dominance, arrhythmia, and pulmonary inflammation Rat Spontaneously Hypertensive Heart Failure (SHHF) rats In vivo 24-port nose-only flow-by inhalation chambers 580 μg/m3 for 4h Synthesized by combining metal compounds in molar ratios comparable to those in the historic residual oil fly ash (ROFA) sample collected as a postcontrol fugitive stack emission at a Florida Power and Light plant burning #6 grade residual oil containing 1% sulfur [67]
Cardiac dysfunction Cardiac and mitochondrial dysfunction Rat Sprague Dawley (SD) rats In vivo Intratracheal instillation 300 μl of vehicle (5% FBS in PBS) with 300 μg of PM for 24 h Collected within one mile of an active mountaintop removal mines (MTM) site [59]
Cardiac dysfunction Exacerbation of viral myocarditis Mouse BALB/c mice In vivo Intratracheal instillation 10 mg/kg for 7d Non-industrial district in Shanghai, China [41]
Cardiac dysfunction Exacerbation of viral myocarditis Mouse BALB/c mice In vivo Intratracheal instillation 10 mg/kg for 7d Non-industrial district in Shanghai, China [42]
Cardiac dysfunction Systemic oxidative stress Mouse ApoE−/− mice, C57BL/6 mice In vivo Intratracheal instillation 3, 10, or 30 mg/kg for 3d Shanghai, China [69]
Cardiac dysfunction Inflammation, oxidative stress, hypercoagulation, cardiomyocyte apoptosis Rat Wistar rats In vivo Intratracheal instillation 0, 4, 40 mg/kg once every 2d for 3 times Beijing, China [53]
Cardiac dysfunction Inflammation, imbalance of oxidative stress, the altered Ca2+ channel related proteins and the increased intracellular free Ca2+, heart impairment Mouse BALB/c mice In vivo Intratracheal instillation 0.01 mg/μl for 2d Hebei, China [46]
Cardiac dysfunction Cardiomyopathy, oxidative stress, fibrosis, inflammation, mitochondrial disorder Mouse C57BL/6J mice; wild type (Nrf2+/+) and Nrf2 knockout (Nrf2−/−) mice In vivo Exposure chamber 50.1 ± 2.5 μg/m3, flow rate of 65 L/min for 6 h/day, 5 times a week, for 24 weeks Yuquan Road, Beijing, China [47]
Cardiac dysfunction Cardiac hypertrophy, fibrosis, metabolic alterations Mouse C57BL/6J mice In vivo Exposure chamber 100 μg/m3, flow rate 3.5-4.0 L/min, exposed for 28 consecutive days (6 h/day), with 2 days of break every 5 days Taipei Main Station, Taiwan [10]
Cardiac dysfunction Increased glycemic homeostasis, inflammation, myocarditis, aortic medial thickness Rat Sprague Dawley (SD) rats In vivo Exposure chamber PM2.5 at ambient concentration for 24 h/day, 7 days/week, for a total of 16 weeks Taipei City, Taiwan [43]
Cardiac dysfunction Impaired oxygen metabolism and contractile function Mouse Swiss mice In vivo Intranasal instillation 1 mg/kg Mystic, Connecticut, USA [91]
Cardiac dysfunction Systemic adverse effects, alterations in lung and cardiac gene expression Mouse BALB/c mice In vivo Intratracheal instillation 100 μg of PM2.5 in 100 μl of isotonic saline solution on d0, d3, d6 Milan, Italy [50]
Cardiac dysfunction Systemic and pulmonary inflammation, decreased left ventricular ejection fraction, pulmonary and myocardial fibrosis and oxidative stress Mouse, human C57BL/6J mice and AMPKα2−/− mice for in vivo, human bronchial epithelial BEAS-2B cells and rat cardio myoblast H9C2 cells for in vitro In vivo, in vitro Intratracheal instillation, Submerged cell culture 10 mg/kg PM2.5 in 10 μl PBS every other day for 4w in vivo, 24h in vitro China [88]
Vascular dysfunction Vascular inflammation, decreased viability, migration and angiogenesis Human Human umbilical vein endothelial cells (HUVECs), human microvascular endothelial cells (HMEC-1) In vitro Submerged cell culture 0–800 μg/ml for 6h NIST Standard Reference Matter (SRM) [77]
Vascular dysfunction Autophagy, FHL2 upregulation, IL-6 production, activation of NF-κB pathway Mouse Mouse aortic endothelial cells (MAECs) In vitro Submerged cell culture 100 μg/ml for 24 h Beijing, China [63]
Vascular dysfunction Oxidative stress and reduced the PAI-1 production of endothelial cells Rat Rat heart microvessel endothelial (RHMVE) cells In vitro Submerged cell culture 0, 5, 10, and 25 μg/ml for 12h Saitama, Japan [78]
Vascular dysfunction Vascular remodeling, exacerbated transition from left ventricular failure to right ventricular hypertrophy Mouse BALB/c mice In vivo Exposure chamber Local PM2.5 for 10h each day for 3w Beijing, China [66]
Vascular dysfunction Atherosclerosis progression, activation of circulating leukocytes, platelets and associated inflammatory factors Mouse ApoE−/− mice In vivo Intratracheal instillation 30 mg/kg each day for 8w Shijiazhuang, China [80]
Vascular dysfunction Disseminated intravascular coagulation, inflammatory response, vascular endothelial injury and prothrombotic state Rat Sprague Dawley (SD) rats In vivo Intratracheal instillation 0, 1.8, 5.4 and 16.2 mg/kg every 3 days for 30d Beijing, China [84]
Vascular dysfunction Autophagy, VEGF induction, inflammation Rat Sprague Dawley (SD) rats In vivo Intratracheal instillation 1.5 mg/kg every 2d for 3 times Wuhan, China [86]
Vascular dysfunction Intracraneal atherosclerosis Rat Sprague Dawley (SD) rats In vivo Exposure chamber Ambient PM2.5 for 6w or 12w Beijing, China [89]
Vascular dysfunction Endoplasmic reticulum instability, ANGII-dependent endothelial dysfunction Rat Sprague Dawley (SD) rats In vivo Intratracheal instillation 1.5 mg/kg every 2d for 3 times Wuhan, China [83]
Vascular dysfunction Endothelial dysfunction, decreased endothelium-dependent relaxation and eNOS expression on pulmonary arteries associated with local inflammation Rat Wistar rats In vivo Exposure chamber Ambient PM2.5 (approx. 600 μg/m3) for 2w São Paulo, Brazil [82]
Cardiac dysfunction Heart failure, acute inflammatory response, chronic matrix remodeling, electrical remodeling, epigenetic changes Mouse FVB mice In utero Exposure chamber average concentration of 73.61 μg/m3, for 6h/day, 7 days/week Columbus, Ohio, USA [51]
Cardiac dysfunction Neonatal cardiac dysfunction Mouse FVB mice In utero Exposure chamber average concentration of 91.87 μg/m3, for 6h/day, 5 days/week throughout gestation period (20 days) Columbus, Ohio, USA [65]
Cardiac dysfunction Cardiac dysfunction Mouse FVB mice In utero Exposure chamber average concentration of 38.58 μg/m3 for 6 hours/day, 5 days/week for 3 months Columbus, Ohio, USA [48]